Smart Watch iECG for the Detection of Cardiac Arrhythmias
Launched by HELIOS HEALTH INSTITUTE GMBH · Sep 16, 2019
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
This diagnostic accuracy study is an investigator-initiated trial to evaluate the value of a smart watch-based iECG for detection of cardiac arrhythmias.
iECG tracings will be recorded simultaneously, starting and ending at the same time as the standard 12-lead ECG, using the built-in sensors of a smart watch (Apple Watch Series 4) with the market version of the ECG application (Apple Inc., California). Participants will be advised to lie down in a supine position and breathe spontaneously. All recording will be done by trained study personnel.
All iECG and 12-lead ECG recordings will be ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged≥22 years at the time of eligibility screening will be included.
- • Patients with known cardiac arrhythmias; i.e. AF before and after cardioversion, hemodynamically stable Bradycardias, SVT and VT during EP procedures and implants can also be included
- Exclusion Criteria:
- • - Pregnancy
About Helios Health Institute Gmbh
Helios Health Institute GmbH is a leading research organization dedicated to advancing medical knowledge through innovative clinical trials. With a focus on developing groundbreaking therapies and treatments, the institute collaborates with healthcare professionals, academic institutions, and pharmaceutical companies to conduct high-quality research. Helios Health Institute GmbH is committed to adhering to rigorous ethical standards and regulatory guidelines, ensuring patient safety and data integrity while striving to bring effective healthcare solutions to market. Through its expertise in various therapeutic areas, the institute plays a pivotal role in transforming scientific discoveries into tangible health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leipzig, , Germany
Patients applied
Trial Officials
Andreas Bollmann, MD, PhD
Study Chair
Heart Center Leipzig at University of Leipzig, Leipzig Heart Institute, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials